IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Kestrel Therapeutics, Inc.
Institut Paoli-Calmettes
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Miami
Dana-Farber Cancer Institute
University of Oklahoma
Mayo Clinic
UNC Lineberger Comprehensive Cancer Center
Tongji Hospital
M.D. Anderson Cancer Center
Washington University School of Medicine
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
West China Hospital
EtiraRx Australia Pty Ltd
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Washington University School of Medicine
Brown University
Mayo Clinic
QuantumLeap Healthcare Collaborative
Sunnybrook Health Sciences Centre
Ohio State University Comprehensive Cancer Center
Rutgers, The State University of New Jersey
Centre Leon Berard
Vanderbilt-Ingram Cancer Center
HonorHealth Research Institute
The Netherlands Cancer Institute
Stanford University
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Abramson Cancer Center at Penn Medicine
Oncology Institute of Southern Switzerland
University of California, San Diego
Dana-Farber Cancer Institute
Masonic Cancer Center, University of Minnesota
H. Lee Moffitt Cancer Center and Research Institute
University of Miami
Alliance for Clinical Trials in Oncology
University of Southern California
Rutgers, The State University of New Jersey
Chinese PLA General Hospital
Washington University School of Medicine
Case Comprehensive Cancer Center
University of Alabama at Birmingham
Yale University
University of Chicago